Biopharma Business

Tag "Pfizer"

Pfizer’s Meningococcal Group B vaccine, Trumenba, gets approval in Europe

    Pfizer’s Meningococcal Group B vaccine, Trumenba, gets approval in Europe

Pfizer has secured approval the European Commission (EC) for TRUMENBA (Meningococcal Group B Vaccine) for preventing invasive meningococcal disease caused by Neisseria meningitidis serogroup B (MenB) in individuals 10 years

Read Full Article

Pfizer collaboration to reduce injectable contraceptive price

    Pfizer collaboration to reduce injectable contraceptive price

“New innovations in contraceptive technology are needed to expand the number of methods available to women and adolescents so they can take charge of their health and their futures.” Pfizer,

Read Full Article

Pfizer gifts the NHS with breast cancer drug

Pfizer has announced it will provide its breast cancer drug, palbociclib — which has been provisionally rejected by NICE for routine use as a result of cost — to the

Read Full Article

Pfizer’s Xeljanz Authorized for Marketing in the European Union

Xeljanz (tofacitinib citrate) receives marketing authorization in the European Union for the treatment of moderate to severe active rheumatoid arthritis (RA). Pfizer Inc. announced today that the European Commission (EC)

Read Full Article

Merck and Pfizer’s diabetes therapy under US, EU review

Regulators on both sides of the Atlantic are reviewing three new submissions for medicines containing ertugliflozin, an investigational SGLT2 inhibitor being developed by Merck and Pfizer to help improve glycaemic

Read Full Article

Big Pharma Firms Were Among Big Investors in Belgium Last Year

Big Pharma companies Pfizer, Sanofi and Johnson & Johnson were among the big investors last year in the Flanders region of Northern Belgium, where U.S. companies alone funded 34 new investment projects, amounting

Read Full Article

Upcoming Events

[eventlist]

The Magazine

New Subscriber

Subscribe Here



Advertisements